Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy

Neurology

Volumn 71, Issue 2, 2008, Pages 122-128

  Moore, A P ^a   Ade Hall, R A ^b   Tudur Smith, C ^b   Rosenbloom, L ^b   Walsh, H P J ^b   Mohamed, K ^b   Williamson, P R ^b  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ABDOMINAL PAIN; ADVERSE OUTCOME; ARTICLE; BACTERIAL INFECTION; CEREBRAL PALSY; CHEST INFECTION; CLINICAL TRIAL; COLD; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROUP; DEVICE INFECTION; DIARRHEA; DISABILITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EAR INFECTION; EVALUATION; FEBRILE CONVULSION; FLU LIKE SYNDROME; GONIOMETRY; HUMAN; INCONTINENCE; KIDNEY INFECTION; LEG MUSCLE; LETHARGY; MOTOR PERFORMANCE; MUSCLE CONTRACTION; MUSCLE CRAMP; NOSE CONGESTION; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SCORING SYSTEM; SEIZURE; SHUNT INFECTION; SIDE EFFECT; SORE THROAT; SPASTICITY; SWELLING; TONSILLITIS; URINARY TRACT INFECTION; VIRUS INFECTION; VOMITING; ARTHROMETRY; FEMALE; INJECTION; MALE; PRESCHOOL CHILD; TREATMENT OUTCOME;

ARTHROMETRY, ARTICULAR; BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS; MALE; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; TREATMENT OUTCOME;

EID: 47549084503     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000316801.74683.c0     Document Type: Article

References (27)

1. Stanley F, Blair E, Alberman E. Cerebral Palsies: Epidemiology & Causal Pathways. London: Mac Keith Press, 2000.
2. Filippi GM, Errico P, Santarelli R, Bagolini B, Manni E. Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol 1993;113:400-404.
3. Manni E, Bagolini B, Pettorossi VE, Errico P. Effect of botulinum toxin on extraocular muscle proprioception. Doc Ophthalmol 1989;72:189-198.
4. Forrsberg HTK. Botulinum toxin treatment in cerebral palsy: intervention with poor evaluation? Dev Med Child Neurol 1997;39:635-640.
5. Graham HK, Aoki KR, Autti-Ramo I, et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 2000;11:67-79.
6. Boyd R, Hays R. Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review. Eur J Neurol 2001;8:1-20.
7. Ade-Hall R, Moore A. Botulinum toxin A in the treatment of lower limb spasticity in cerebral palsy. Cochrane Database Syst Rev 2000;(2):CD001408.
8. Koman L, Mooney J, Smith B, Walker F, Leon J; BOTOX Study Group. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. J Pediatr Orthop 2000;20:108-115.
9. Ubhi T, Bhakta B, Ives H, Allgar V, Roussounis S. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child 2000;83:481-487.
10. Kanovsky P, Bares M, Severa S, et al. Functional benefit of botulinum toxin (Dysport) in the treatment of dynamic equinus cerebral palsy spasticity: a prospective, multicentre, double-blind, placebo-controlled study. Naunyn Schmiedebergs Arch Pharmacol 2002;365:R25.
11. Baker R, Jasisinski M, Maciag-Tymecka I, et al. Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomised, double-blind, placebo-controlled, dose-ranging study. Dev Med Child Neurol 2002;44:666-675.
12. Love S, Valentine J, Blair E, Price C, Cole J, Chauvel P. The effect of botulinum toxin A on the functional ability of the child with spastic hemiplegia: a randomised controlled trial. Eur J Neurol 2001;8:50-58.
13. Reddihough D, King J, Coleman G, et al. Functional outcome of botulinum toxin A injections to the lower limbs in cerebral palsy. Dev Med Child Neurol 2002;44:820-827.
14. Koman LA, Mooney JF, Smith BP, Goodman A, Mulvaney T. Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. J Pediatr Orthop 1994;14:299-303.
15. Russell DJ, Rosenbaum PL, Cadman DT, Gowland C, Hardy S, Jarvis S. The gross motor function measure: a means to evaluate the effects of physical therapy. Dev Med Child Neurol 1989;31:341-352.
16. Boyce WF, Gowland C, Rosenbaum PL, et al. Measuring quality of movement in cerebral palsy: a review of instruments. Phys Ther 1991;71:813-819.
17. Nichols DS, Case-Smith J. Reliability and validity of the Pediatric Evaluation of Disability Inventory. Paediatr Phys Ther 1996;8:15-24.
18. Russell D, Rosenbaum P, Gowland C, et al. Gross Motor Function Measure Manual. Hamilton: McMaster University, 1993.
19. Moore A, Ade-Hall R, McDowell M, Rosenbloom L, Mo-hamed K, Walsh H. Children with cerebral palsy tolerate repeated botulinum toxin injection sessions without general anaesthetic. Mov Disord 2001;16:381. Abstract.
20. Misra P. The changed image of botulinum toxin. BMJ 2002;325:1188.
21. Sheean G. Botulinum treatment of spasticity: why is it so difficult to show a functional benefit? Curr Opin Neurol 2001;14:771-775.
22. Cosgrove AP, Corry IS, Graham HK. Botulinum toxin A in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1994;36:386-396.
23. Damiano DL, Abel MF. Relationship of gait analysis to gross motor function in cerebral palsy. Dev Med Child Neurol 1996;38:389-396.
24. Boyd R, Graham H. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol 1999;6:S23-S35.
25. Rosenbaum P, Walter S, Hanna S, et al. Prognosis for gross motor function in cerebral palsy. creation of motor development curves. JAMA 2002;288:1357-1363.
26. Chin TY, Nattrass GR, Selber P, Graham HK. Accuracy of intramuscular injection of botulinum toxin A in juvenile cerebral palsy: a comparison between manual needle placement and placement guided by electrical stimulation. J Pe-diatr Orthop 2005;25:286-291.
27. Berweck S, Schroeder A, Fietzek U, Heinen F. Sonography-guided injection of botulinum toxin in children with cerebral palsy. Lancet 2004;363:249-250.